Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Breastcancer × Trastuzumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 190 Stomach Neoplasms 29 Neoplasm Metastasis 24 Neoplasms 17 Colorectal Neoplasms 11 HER2-positive Breast Cancer 10 Brain Neoplasms 10 Carcinoma, Non-Small-Cell Lung 8 Esophageal Neoplasms 5 Triple Negative Breast Neoplasms 4 Ovarian Neoplasms 4 Adenocarcinoma Of Esophagus 4 Squamous Cell Carcinoma of Head and Neck 3 Pancreatic Neoplasms 3 Endometrial Neoplasms 3 Carcinoma 3 Uterine Cervical Neoplasms 2 Urologic Neoplasms 2 Urinary Bladder Neoplasms 2 Solid Tumors 2 Sarcoma 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 HER2-positive Gastric Cancer 2 HER2-positive Early Breast Cancer 2 Breast Cancer Metastatic 2 Solid Tumor, Adult 1 Solid Tumor 1 Solid Cancers 1 Solid Cancer 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03014076 2017-01-09

Immunotherapy Vaccine and Herceptin in Breast Cancer

Cancer Insight, LLC

Phase 1 Completed

Breastcancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡